Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP544778.RAo6A3QBn77nYBKRrDGFkE9lrwrduxmVbdquPrLyymsY8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP544778.RAo6A3QBn77nYBKRrDGFkE9lrwrduxmVbdquPrLyymsY8130_assertion type Assertion NP544778.RAo6A3QBn77nYBKRrDGFkE9lrwrduxmVbdquPrLyymsY8130_head.
- NP544778.RAo6A3QBn77nYBKRrDGFkE9lrwrduxmVbdquPrLyymsY8130_assertion description "[Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP544778.RAo6A3QBn77nYBKRrDGFkE9lrwrduxmVbdquPrLyymsY8130_provenance.
- NP544778.RAo6A3QBn77nYBKRrDGFkE9lrwrduxmVbdquPrLyymsY8130_assertion evidence source_evidence_literature NP544778.RAo6A3QBn77nYBKRrDGFkE9lrwrduxmVbdquPrLyymsY8130_provenance.
- NP544778.RAo6A3QBn77nYBKRrDGFkE9lrwrduxmVbdquPrLyymsY8130_assertion SIO_000772 7545221 NP544778.RAo6A3QBn77nYBKRrDGFkE9lrwrduxmVbdquPrLyymsY8130_provenance.
- NP544778.RAo6A3QBn77nYBKRrDGFkE9lrwrduxmVbdquPrLyymsY8130_assertion wasDerivedFrom befree-20150227 NP544778.RAo6A3QBn77nYBKRrDGFkE9lrwrduxmVbdquPrLyymsY8130_provenance.
- NP544778.RAo6A3QBn77nYBKRrDGFkE9lrwrduxmVbdquPrLyymsY8130_assertion wasGeneratedBy ECO_0000203 NP544778.RAo6A3QBn77nYBKRrDGFkE9lrwrduxmVbdquPrLyymsY8130_provenance.